BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 31301162)

  • 21. Diagnostic utility of high-risk human papillomavirus mRNA in situ hybridisation in squamous cell carcinoma of unknown primary in the head and neck and implementing American Society of Clinical Oncology guideline recommendations.
    Daneshpajouhnejad P; Miller JA; Maleki Z
    Cytopathology; 2020 Nov; 31(6):547-554. PubMed ID: 32735747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Head and neck squamous cell carcinoma of unknown primary: neck dissection and radiotherapy or definitive radiotherapy.
    Demiroz C; Vainshtein JM; Koukourakis GV; Gutfeld O; Prince ME; Bradford CR; Wolf GT; McLean S; Worden FP; Chepeha DB; Schipper MJ; McHugh JB
    Head Neck; 2014 Nov; 36(11):1589-1595. PubMed ID: 23996575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective review of positron emission tomography with contrast-enhanced computed tomography in the posttreatment setting in human papillomavirus-associated oropharyngeal carcinoma.
    Chan JY; Sanguineti G; Richmon JD; Marur S; Gourin CG; Koch W; Chung CH; Quon H; Bishop JA; Aygun N; Agrawal N
    Arch Otolaryngol Head Neck Surg; 2012 Nov; 138(11):1040-6. PubMed ID: 23165378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Value of Radiologic Extranodal Extension in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.
    Lee B; Choi YJ; Kim SO; Lee YS; Hong JY; Baek JH; Lee JH
    Korean J Radiol; 2019 Aug; 20(8):1266-1274. PubMed ID: 31339014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies against human papillomaviruses as diagnostic and prognostic biomarker in patients with neck squamous cell carcinoma from unknown primary tumor.
    Schroeder L; Wichmann G; Willner M; Michel A; Wiesenfarth M; Flechtenmacher C; Gradistanac T; Pawlita M; Dietz A; Waterboer T; Holzinger D
    Int J Cancer; 2018 Apr; 142(7):1361-1368. PubMed ID: 29159804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cervical lymph node metastases of squamous cell carcinoma of unknown origin: the diagnostic value of FDG PET/CT and clinical outcome.
    Dale E; Moan JM; Osnes TA; Bogsrud TV
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):1015-1019. PubMed ID: 27671150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneity of p16 immunohistochemistry and increased sensitivity of RNA in situ hybridization in cytology specimens of HPV-related head and neck squamous cell carcinoma.
    Wong KS; Krane JF; Jo VY
    Cancer Cytopathol; 2019 Oct; 127(10):632-642. PubMed ID: 31509355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP).
    Balk M; Rupp R; Mantsopoulos K; Allner M; Grundtner P; Mueller SK; Traxdorf M; Eckstein M; Speer S; Semrau S; Fietkau R; Iro H; Hecht M; Gostian AO
    BMC Cancer; 2021 Nov; 21(1):1236. PubMed ID: 34794411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary surgery for human papillomavirus-associated oropharyngeal cancer: Survival outcomes with or without adjuvant treatment.
    Cramer JD; Ferris RL; Kim S; Duvvuri U
    Oral Oncol; 2018 Dec; 87():170-176. PubMed ID: 30527235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transoral robotic surgery for the management of head and neck squamous cell carcinoma of unknown primary.
    Channir HI; Rubek N; Nielsen HU; Kiss K; Charabi BW; Lajer CB; von Buchwald C
    Acta Otolaryngol; 2015; 135(10):1051-7. PubMed ID: 26073750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Updates in the management of unknown primary of the head and neck.
    Kalavacherla S; Sanghvi P; Lin GY; Guo T
    Front Oncol; 2022; 12():991838. PubMed ID: 36185196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection and Oncologic Outcomes of Head and Neck Squamous Cell Carcinoma of Unknown Primary Origin.
    Lee MY; Fowler N; Adelstein D; Koyfman S; Prendes B; Burkey BB
    Anticancer Res; 2020 Aug; 40(8):4207-4214. PubMed ID: 32727746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p16 immunohistochemistry for primary tumor detection in HPV-positive squamous cell carcinoma of unknown primary.
    Shan A; Rooper LM; Ryan JF; Eisele DW; Fakhry C
    Am J Otolaryngol; 2021; 42(5):103015. PubMed ID: 33857776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positron Emission Tomography-Computed Tomography Surveillance after (Chemo)Radiotherapy in Advanced Head and Neck Squamous Cell Cancer: Beyond the PET-NECK Protocol.
    Zhou S; Rulach R; Hendry F; Stobo D; James A; Dempsey MF; Grose D; Lamb C; Schipani S; Rizwanullah M; Wilson C; Lau YC; Paterson C
    Clin Oncol (R Coll Radiol); 2020 Oct; 32(10):665-673. PubMed ID: 32561027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current Standard of Care in Squamous Cell Carcinoma of the Head and Neck (SCCHN) - Prevention, diagnostics, prognostication and therapy].
    Pogorzelski M; Grünwald V
    Dtsch Med Wochenschr; 2019 Dec; 144(24):1691-1696. PubMed ID: 31791073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of palatine tonsillectomy in the diagnostic workup of head and neck squamous cell carcinoma of unknown primary origin: A systematic review and meta-analysis.
    Di Maio P; Iocca O; De Virgilio A; Ferreli F; Cristalli G; Pellini R; Golusinski P; Ricci G; Spriano G
    Head Neck; 2019 Apr; 41(4):1112-1121. PubMed ID: 30575162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-Treatment Neck Dissection of Tonsillar and Base of Tongue Squamous Cell Carcinoma in the Era of PET-CT, HPV, and p16.
    Landin D; Näsman A; Jara SJ; Hammarstedt-Nordenvall L; Munck-Wikland E; Dalianis T; Marklund L
    Viruses; 2022 Jul; 14(8):. PubMed ID: 36016315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of multimodality treatment on overall survival for patients with metastatic or recurrent HPV-positive head and neck squamous cell carcinoma.
    Deeken JF; Newkirk K; Harter KW; Marshall MB; Banovac F; Johnson L; Wang H; Wang Y; Zhuang T; Jay AK; Berkowitz F; Esposito G; Kallakury B; Davidson B
    Head Neck; 2015 May; 37(5):630-5. PubMed ID: 24616038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of human papillomavirus-related unknown primaries of the head and neck with a transoral surgical approach.
    Graboyes EM; Sinha P; Thorstad WL; Rich JT; Haughey BH
    Head Neck; 2015 Nov; 37(11):1603-11. PubMed ID: 24931847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.